Home > Boards > US Listed > Biotechs > Sorrento Therapeutics, Inc. (SRNE)

Get lost

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
maximumgriff Member Profile
 
Followed By 67
Posts 5,099
Boards Moderated 0
Alias Born 03/07/17
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 7/1/2020 4:39:29 PM
Sorrento Announces Selection of T-VIVA-19™ as Targeted Protein Vaccine Candidate for SARS-CoV-2 GlobeNewswire Inc. - 7/1/2020 12:06:40 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/30/2020 4:37:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/15/2020 6:11:43 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/15/2020 6:11:32 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/15/2020 6:11:02 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/15/2020 6:10:52 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/15/2020 6:10:27 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/15/2020 6:09:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/15/2020 6:09:22 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/15/2020 6:08:57 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/15/2020 6:08:36 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/12/2020 4:12:16 PM
Sorrento Announces Full Repayment of Outstanding Term Loans GlobeNewswire Inc. - 6/12/2020 3:21:08 PM
Sorrento Announces It Has Submitted an Emergency Use Authorization (EUA) Application for the COVI-TRACK Diagnostic Test for t... GlobeNewswire Inc. - 6/10/2020 9:57:56 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/5/2020 9:32:15 AM
Sorrento COVIDTRAP™(STI-4398) Demonstrates in Preclinical Studies its Ability to Completely Inhibit SARS-CoV-2 Viral Infect... PR Newswire (US) - 6/5/2020 9:30:00 AM
Sorrento Receives FDA IND Clearance to Initiate a Phase I Clinical Trial of its CD38 Antibody-Drug Conjugate (ADC) STI-6129 f... GlobeNewswire Inc. - 5/26/2020 9:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/21/2020 7:01:41 AM
Sorrento Enters Into Binding Term Sheet to Acquire Exclusive Rights to Abivertinib with Completed Registrational Trial Data i... GlobeNewswire Inc. - 5/21/2020 7:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/15/2020 1:53:22 PM
STI-1499, A Potent Anti-SARS-CoV-2 Antibody, Demonstrates Ability To Completely Inhibit In Vitro Virus Infection In Preclinic... PR Newswire (US) - 5/15/2020 11:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/11/2020 4:03:59 PM
Sorrento And Mount Sinai Health System To Jointly Develop COVI-SHIELD™ Antibody Therapy Targeting SARS-CoV-2 Infection (COV... PR Newswire (US) - 5/8/2020 9:20:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 4/27/2020 4:39:40 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist